Verastem (VSTM)
(Delayed Data from NSDQ)
$9.38 USD
+0.17 (1.79%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $9.35 -0.03 (-0.32%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Income Statements
Fiscal Year end for Verastem, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 3 | 2 | 89 | 17 |
Cost Of Goods | 0 | 0 | 0 | 34 | 3 |
Gross Profit | 0 | 3 | 2 | 55 | 15 |
Selling & Adminstrative & Depr. & Amort Expenses | 92 | 76 | 63 | 104 | 147 |
Income After Depreciation & Amortization | -92 | -73 | -61 | -49 | -132 |
Non-Operating Income | 9 | 1 | 0 | -2 | 4 |
Interest Expense | 4 | 2 | 10 | 16 | 21 |
Pretax Income | -87 | -74 | -71 | -68 | -149 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -87 | -74 | -71 | -68 | -149 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -87 | -74 | -71 | -68 | -149 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -93 | -73 | -52 | -38 | -123 |
Depreciation & Amortization (Cash Flow) | -1 | 0 | 9 | 12 | 9 |
Income After Depreciation & Amortization | -92 | -73 | -61 | -49 | -132 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 22.05 | 16.13 | 14.53 | 12.77 | 6.21 |
Diluted EPS Before Non-Recurring Items | -3.96 | -4.56 | -4.92 | -5.28 | -24.01 |
Diluted Net EPS (GAAP) | -3.96 | -4.56 | -4.92 | -5.28 | -24.01 |
Fiscal Year end for Verastem, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 31.14 | 21.31 | 20.29 | 19.35 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -31.14 | -21.31 | -20.29 | -19.35 |
Non-Operating Income | NA | 4.37 | 2.43 | 1.08 | 0.97 |
Interest Expense | NA | 1.12 | 1.13 | 1.12 | 0.77 |
Pretax Income | NA | -27.89 | -20.00 | -20.33 | -19.14 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -27.89 | -20.00 | -20.33 | -19.14 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -27.89 | -20.00 | -20.33 | -19.14 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 26.81 | 26.79 | 17.73 | 16.72 |
Diluted EPS Before Non-Recurring Items | NA | -1.02 | -0.75 | -1.37 | -0.96 |
Diluted Net EPS (GAAP) | NA | -0.88 | -0.75 | -1.37 | -0.96 |